Summary

The global balloon infusers market is witnessing remarkable growth, driven by rising demand for advanced drug delivery methods, particularly in pain management and oncology. These portable, lightweight devices provide a controlled method for administering medication and are increasingly being adopted across hospitals, ambulatory surgical centers, and home care settings. The market, valued at US$ 1.4 Bn in 2025, is projected to reach US$ 2.9 Bn by 2032, growing at a robust CAGR of 10.26% during the forecast period of 2025 to 2032.

Market Insights

Balloon infusers, often categorized as elastomeric infusion pumps, are becoming a critical part of post-operative care and chronic disease management. These devices offer either continuous or variable drug flow, depending on patient needs. Their popularity stems from their reliability, portability, and ability to deliver medication in outpatient or home environments without requiring electricity.

The increasing burden of chronic diseases, particularly cancer and cardiovascular conditions, has created a favorable environment for the adoption of these devices. Additionally, the surge in surgeries, especially orthopedic procedures, has accelerated the demand for effective post-surgical pain management solutions.

Key Drivers Shaping the Market

A major factor fueling the growth of the balloon infusers market is the rising number of cancer cases globally. The need for continuous infusion in chemotherapy, combined with the rise in surgical procedures such as hip and knee replacements, is further contributing to the demand.

Moreover, balloon infusers are preferred over traditional electric pumps due to their simplicity, lightweight design, and cost-efficiency in ambulatory and home settings. This makes them highly suitable for resource-limited healthcare environments and promotes their widespread adoption.

The integration of regional anesthesia techniques using balloon infusers is also enhancing patient outcomes. These pumps allow for early discharge post-surgery by effectively managing pain with reduced opioid dependency, thus contributing to overall healthcare cost reduction.

Business Opportunities

The expanding scope of balloon infusers in non-hospital settings is opening new avenues for manufacturers. As healthcare systems worldwide shift towards outpatient care, the demand for wearable and disposable infusion pumps is expected to rise.

The growing acceptance of balloon infusers in dental clinics, cancer care centers, and specialty clinics also presents significant business opportunities. Enhanced R&D efforts and advancements in infusion technologies are encouraging product innovation. The availability of various balloon infuser models — including single-use, continuous rate, and variable rate pumps — further diversifies the market Analysis.

Despite the opportunities, high device costs and stringent regulatory standards pose challenges. Price fluctuations, especially for pain management pumps, and concerns regarding the use of certain plastics such as DEHP and PVC, necessitate innovation in materials and compliance with evolving safety standards.

Regional Analysis

The United States leads the global balloon infusers market, driven by a growing patient base with chronic diseases and an advanced healthcare infrastructure. The region benefits from strong R&D activities and favorable reimbursement policies that support the adoption of innovative infusion therapies.

Germany is a key contributor in the European market, supported by the presence of major pharmaceutical and biotech firms and increasing government investments in healthcare. The rise in geriatric population and chronic disease prevalence are bolstering the country's market growth.

In South Asia, India is emerging as a high-potential market, propelled by improvements in healthcare infrastructure, rising patient awareness, and increased investments in the medical device sector. The growing number of hospitals and expanding access to advanced therapies are expected to fuel further demand for balloon infusers.

Key Players

The competitive Analysis of the balloon infusers market is marked by continuous innovation and strategic collaborations. Key players include:

• B. Braun Melsungen AG

• Fresenius Kabi AG

• Baxter International Inc.

• Terumo Corporation

• Nipro Corporation

• Smiths Medical

• Avanos Medical, Inc.

• Ambu A/S

• Pfm Medical AG

• Daiken Medical Co., Ltd.

• Palex Medical SA

• Canack Technology Ltd.

• PROMECON GmbH

• Halomedical Systems Ltd.

These companies are actively focusing on product launches, mergers, and expansions to strengthen their global footprint and cater to the increasing demand for effective drug delivery solutions.

Market Segmentation

By Product:

• Continuous Rate Elastomeric Pumps

• Variable Rate Elastomeric Pumps

By Application:

• Pain Management

• Antibiotic Therapy

• Antiviral Therapy

• Chemotherapy

• Others

By End User:

• Hospitals

• Ambulatory Surgical Centres

• Home Care Settings

• Specialty Clinics

• Others

By Region:

• North America

• Latin America

• Europe

• East Asia

• South Asia

• Oceania

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Balloon Infusers Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019-2024
3.1. Global Average Price Analysis, by Product/ Application, US$ Per Unit, 2019-2024
3.2. Prominent Factor Affecting Breast Tissue Markers Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Balloon Infusers Market Outlook, 2019-2032
4.1. Global Balloon Infusers Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Continuous Rate Elastomeric Pumps
4.1.1.2. Variable Rate Elastomeric Pumps
4.2. Global Balloon Infusers Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Pain Management
4.2.1.2. Antibiotic Therapy
4.2.1.3. Antiviral Therapy
4.2.1.4. Chemotherapy
4.2.1.5. Others
4.3. Global Balloon Infusers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgical Centres
4.3.1.3. Home Care Settings
4.3.1.4. Speciality Clinics
4.3.1.5. Others
4.4. Global Balloon Infusers Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Balloon Infusers Market Outlook, 2019-2032
5.1. North America Balloon Infusers Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Continuous Rate Elastomeric Pumps
5.1.1.2. Variable Rate Elastomeric Pumps
5.2. North America Balloon Infusers Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Pain Management
5.2.1.2. Antibiotic Therapy
5.2.1.3. Antiviral Therapy
5.2.1.4. Chemotherapy
5.2.1.5. Others
5.3. North America Balloon Infusers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centres
5.3.1.3. Home Care Settings
5.3.1.4. Speciality Clinics
5.3.1.5. Others
5.4. North America Balloon Infusers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. U.S. Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.2. U.S. Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.3. U.S. Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.4. Canada Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.5. Canada Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.6. Canada Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Balloon Infusers Market Outlook, 2019-2032
6.1. Europe Balloon Infusers Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Continuous Rate Elastomeric Pumps
6.1.1.2. Variable Rate Elastomeric Pumps
6.2. Europe Balloon Infusers Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Pain Management
6.2.1.2. Antibiotic Therapy
6.2.1.3. Antiviral Therapy
6.2.1.4. Chemotherapy
6.2.1.5. Others
6.3. Europe Balloon Infusers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centres
6.3.1.3. Home Care Settings
6.3.1.4. Speciality Clinics
6.3.1.5. Others
6.4. Europe Balloon Infusers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Germany Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.2. Germany Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.3. Germany Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.4. U.K. Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.5. U.K. Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.6. U.K. Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.7. France Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.8. France Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.9. France Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.10. Italy Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.11. Italy Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.12. Italy Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.13. Turkey Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.14. Turkey Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.15. Turkey Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.16. Russia Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.17. Russia Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.18. Russia Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.19. Rest of Europe Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.20. Rest of Europe Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.21. Rest of Europe Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Balloon Infusers Market Outlook, 2019-2032
7.1. Asia Pacific Balloon Infusers Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Continuous Rate Elastomeric Pumps
7.1.1.2. Variable Rate Elastomeric Pumps
7.2. Asia Pacific Balloon Infusers Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Pain Management
7.2.1.2. Antibiotic Therapy
7.2.1.3. Antiviral Therapy
7.2.1.4. Chemotherapy
7.2.1.5. Others
7.3. Asia Pacific Balloon Infusers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centres
7.3.1.3. Home Care Settings
7.3.1.4. Speciality Clinics
7.3.1.5. Others
7.4. Asia Pacific Balloon Infusers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. China Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.2. China Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.3. China Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.4. Japan Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.5. Japan Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.6. Japan Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.7. South Korea Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.8. South Korea Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.9. South Korea Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.10. India Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.11. India Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.12. India Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.13. Southeast Asia Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.14. Southeast Asia Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.15. Southeast Asia Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.16. Rest of Asia Pacific Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.17. Rest of Asia Pacific Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.18. Rest of Asia Pacific Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Balloon Infusers Market Outlook, 2019-2032
8.1. Latin America Balloon Infusers Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Continuous Rate Elastomeric Pumps
8.1.1.2. Variable Rate Elastomeric Pumps
8.2. Latin America Balloon Infusers Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1.1. Pain Management
8.2.1.2. Antibiotic Therapy
8.2.1.3. Antiviral Therapy
8.2.1.4. Chemotherapy
8.2.1.5. Others
8.3. Latin America Balloon Infusers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centres
8.3.1.3. Home Care Settings
8.3.1.4. Speciality Clinics
8.3.1.5. Others
8.4. Latin America Balloon Infusers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Brazil Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.2. Brazil Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.3. Brazil Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.4. Mexico Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.5. Mexico Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.6. Mexico Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.7. Argentina Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.8. Argentina Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.9. Argentina Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.10. Rest of Latin America Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.11. Rest of Latin America Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.12. Rest of Latin America Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Balloon Infusers Market Outlook, 2019-2032
9.1. Middle East & Africa Balloon Infusers Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Continuous Rate Elastomeric Pumps
9.1.1.2. Variable Rate Elastomeric Pumps
9.2. Middle East & Africa Balloon Infusers Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Pain Management
9.2.1.2. Antibiotic Therapy
9.2.1.3. Antiviral Therapy
9.2.1.4. Chemotherapy
9.2.1.5. Others
9.3. Middle East & Africa Balloon Infusers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Ambulatory Surgical Centres
9.3.1.3. Home Care Settings
9.3.1.4. Speciality Clinics
9.3.1.5. Others
9.4. Middle East & Africa Balloon Infusers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. GCC Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.2. GCC Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.3. GCC Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.4. South Africa Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.5. South Africa Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.6. South Africa Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.7. Egypt Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.8. Egypt Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.9. Egypt Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.10. Nigeria Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.11. Nigeria Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.12. Nigeria Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.13. Rest of Middle East & Africa Balloon Infusers Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.14. Rest of Middle East & Africa Balloon Infusers Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.15. Rest of Middle East & Africa Balloon Infusers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Product vs Indication Heatmap
10.2. Manufacturer vs Indication Heatmap
10.3. Company Market Share Analysis, 2025
10.4. Competitive Dashboard
10.5. Company Profiles
10.5.1. B. Braun Melsungen AG
10.5.1.1. Company Overview
10.5.1.2. Product Portfolio
10.5.1.3. Financial Overview
10.5.1.4. Business Strategies and Development
10.5.2. Fresenius Kabi AG
10.5.2.1. Company Overview
10.5.2.2. Product Portfolio
10.5.2.3. Financial Overview
10.5.2.4. Business Strategies and Development
10.5.3. Baxter International Inc.
10.5.3.1. Company Overview
10.5.3.2. Product Portfolio
10.5.3.3. Financial Overview
10.5.3.4. Business Strategies and Development
10.5.4. Terumo Corporation
10.5.4.1. Company Overview
10.5.4.2. Product Portfolio
10.5.4.3. Financial Overview
10.5.4.4. Business Strategies and Development
10.5.5. Nipro Corporation
10.5.5.1. Company Overview
10.5.5.2. Product Portfolio
10.5.5.3. Financial Overview
10.5.5.4. Business Strategies and Development
10.5.6. Smiths Medical
10.5.6.1. Company Overview
10.5.6.2. Product Portfolio
10.5.6.3. Financial Overview
10.5.6.4. Business Strategies and Development
10.5.7. Avanos Medical, Inc.
10.5.7.1. Company Overview
10.5.7.2. Product Portfolio
10.5.7.3. Financial Overview
10.5.7.4. Business Strategies and Development
10.5.8. Ambu A/S
10.5.8.1. Company Overview
10.5.8.2. Product Portfolio
10.5.8.3. Financial Overview
10.5.8.4. Business Strategies and Development
10.5.9. Pfm Medical Ag
10.5.9.1. Company Overview
10.5.9.2. Product Portfolio
10.5.9.3. Financial Overview
10.5.9.4. Business Strategies and Development
10.5.10. Daiken Medical Co., Ltd.
10.5.10.1. Company Overview
10.5.10.2. Product Portfolio
10.5.10.3. Financial Overview
10.5.10.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations